<DOC>
	<DOCNO>NCT00004012</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness capecitabine treat patient recurrent ovarian , fallopian tube , primary peritoneal cancer .</brief_summary>
	<brief_title>Capecitabine Treating Patients With Recurrent Ovarian , Fallopian Tube , Primary Peritoneal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate time treatment failure patient recurrent ovarian epithelial , fallopian tube , primary peritoneal carcinoma treat oral capecitabine . II . Determine tolerability safety regimen patient . OUTLINE : Patients receive oral capecitabine twice daily 14 day . Treatment continue every 3 week absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 14-35 patient accrue study .</detailed_description>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm recurrent ovarian epithelial carcinoma , fallopian tube cancer , primary peritoneal cancer previously treat least one cisplatin base chemotherapy regimen Prior repeat treatment taxane and/or platinum agent allow Prior repeat treatment chemotherapy agent allow Recurrent disease define : At least one site measurable disease radiograph and/or rise CA125 minimum 3 sample level least 50 % upper limit normal PATIENT CHARACTERISTICS : Age : Not specify Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 2.0 time upper limit normal ( ULN ) SGOT le 2.0 time ULN Alkaline phosphatase less 2.0 time ULN Renal : Creatinine great 1.5 mg/dL Other : Must able take oral medication PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics No prior fluorouracil base chemotherapy Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>primary peritoneal cavity cancer</keyword>
</DOC>